157 related articles for article (PubMed ID: 12837756)
1. Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.
Alvarez Arias D; Navenot JM; Zhang WB; Broach J; Peiper SC
J Biol Chem; 2003 Sep; 278(38):36513-21. PubMed ID: 12837756
[TBL] [Abstract][Full Text] [Related]
2. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
3. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
[TBL] [Abstract][Full Text] [Related]
4. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.
Lee B; Doranz BJ; Rana S; Yi Y; Mellado M; Frade JM; Martinez-A C; O'Brien SJ; Dean M; Collman RG; Doms RW
J Virol; 1998 Sep; 72(9):7450-8. PubMed ID: 9696841
[TBL] [Abstract][Full Text] [Related]
5. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
6. Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.
Corbisier J; Huszagh A; Galés C; Parmentier M; Springael JY
J Biol Chem; 2017 Jan; 292(2):575-584. PubMed ID: 27895119
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection.
Salentin R; Gemsa D; Sprenger H; Kaufmann A
J Leukoc Biol; 2003 Aug; 74(2):252-9. PubMed ID: 12885942
[TBL] [Abstract][Full Text] [Related]
8. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
9. The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation.
Govaerts C; Blanpain C; Deupi X; Ballet S; Ballesteros JA; Wodak SJ; Vassart G; Pardo L; Parmentier M
J Biol Chem; 2001 Apr; 276(16):13217-25. PubMed ID: 11278962
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
11. Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes.
Nomiyama H; Hieshima K; Nakayama T; Sakaguchi T; Fujisawa R; Tanase S; Nishiura H; Matsuno K; Takamori H; Tabira Y; Yamamoto T; Miura R; Yoshie O
Int Immunol; 2001 Aug; 13(8):1021-9. PubMed ID: 11470772
[TBL] [Abstract][Full Text] [Related]
12. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
[TBL] [Abstract][Full Text] [Related]
13. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
[TBL] [Abstract][Full Text] [Related]
14. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
[TBL] [Abstract][Full Text] [Related]
15. The lupane-type triterpene 30-oxo-calenduladiol is a CCR5 antagonist with anti-HIV-1 and anti-chemotactic activities.
Barroso-González J; El Jaber-Vazdekis N; García-Expósito L; Machado JD; Zárate R; Ravelo ÁG; Estévez-Braun A; Valenzuela-Fernández A
J Biol Chem; 2009 Jun; 284(24):16609-16620. PubMed ID: 19386595
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts.
Rüster M; Sperschneider H; Fünfstück R; Stein G; Gröne HJ
Clin Nephrol; 2004 Jan; 61(1):30-9. PubMed ID: 14964455
[TBL] [Abstract][Full Text] [Related]
17. Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.
Lebre MC; Vergunst CE; Choi IY; Aarrass S; Oliveira AS; Wyant T; Horuk R; Reedquist KA; Tak PP
PLoS One; 2011; 6(7):e21772. PubMed ID: 21747955
[TBL] [Abstract][Full Text] [Related]
18. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
Zhang WB; Navenot JM; Haribabu B; Tamamura H; Hiramatu K; Omagari A; Pei G; Manfredi JP; Fujii N; Broach JR; Peiper SC
J Biol Chem; 2002 Jul; 277(27):24515-21. PubMed ID: 11923301
[TBL] [Abstract][Full Text] [Related]
19. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis.
Hecht I; Cahalon L; Hershkoviz R; Lahat A; Franitza S; Lider O
Int Immunol; 2003 Jan; 15(1):29-38. PubMed ID: 12502723
[TBL] [Abstract][Full Text] [Related]
20. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5.
Ogilvie P; Bardi G; Clark-Lewis I; Baggiolini M; Uguccioni M
Blood; 2001 Apr; 97(7):1920-4. PubMed ID: 11264152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
